Development of a novel highly anti-proliferative family of gold complexes: Au(i)-phosphonium-phosphines. Issue 14 (22nd March 2021)

• Record Type: Journal Article
• Authors: Rousselle, Benjamin; Bouyer, Florence; Bayardon, Jérôme; Laly, Myriam; Ghiringhelli, François; Rousselin, Yoann; Bodio, Ewen; Malacea-Kabbara, Raluca
• Is Part Of: Dalton transactions. Volume 50:Issue 14(2021)
• Page Start: 4880
• Page End: 4889
• Publication Date: 2021-03-22
• Subjects: Chemistry, Inorganic -- Periodicals; Chemistry, Physical and theoretical -- Periodicals; Chemistry, Inorganic -- Periodicals; 546.05
• DOI: 10.1039/d0dt03708g
• Languages: English
• ISSNs: 1477-9226

Abstract

Abstract : The strong anti-proliferative properties of an original family of gold(i ) complexes were assessed (submicromolar range activity). Abstract : A family of gold(i )-phosphonium-phosphine complexes was synthesized thanks to an efficient 5-step strategy, which involves a phospha-Fries rearrangement. It enables the facile variation of the phosphonium moiety. All the complexes along with a synthetic intermediate were fully characterized (a crystal structure was obtained for two of them). The antiproliferative properties of the six novel complexes were evaluated on three human cancer cell lines (A549, MDA-MB-231, and SW480) and compared to those of three benchmark anticancer drugs used in clinics (oxaliplatin, 5-fluorouracil, and paclitaxel ) and to a phosphonium-free gold(i ) complex [Au(PPh3 )Br]. All the gold(i ) complexes, containing a phosphonium, displayed strong anti-proliferative properties. They were more efficient than oxaliplatin and 5-fluorouracil, and one of the complexes was even more efficient than paclitaxel .